Metraipolis › archive › dc_f74291168fb2
PSMB9 Orchestrates Tumor Immune Landscape and Serves as a Potent Biomarker for Prognosis and T Cell-Based Immunotherapy Response — Europe PMC PMID:41020834
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41020834
- DOI
- 10.3390/cimb47090712
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T04:26:42.883Z
- SHA-256 of the archived text
73409ddc5d5c326f330b3d785bbff4148b9247beab0d24e15404a53dfd87fcd0- Stable URL of this page
https://metraipolis.com/documento/dc_f74291168fb2
How to cite
PSMB9 Orchestrates Tumor Immune Landscape and Serves as a Potent Biomarker for Prognosis and T Cell-Based Immunotherapy Response — Europe PMC PMID:41020834 — Europe PMC (en), https://europepmc.org/article/MED/41020834 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f74291168fb2 (Metraipolis archive dc_f74291168fb2, sha256 73409ddc5d5c326f330b3d785bbff4148b9247beab0d24e15404a53dfd87fcd0)
BibTeX
@misc{dcf74291168fb2,
title = {PSMB9 Orchestrates Tumor Immune Landscape and Serves as a Potent Biomarker for Prognosis and T Cell-Based Immunotherapy Response — Europe PMC PMID:41020834},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41020834},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f74291168fb2; sha256 73409ddc5d5c326f330b3d785bbff4148b9247beab0d24e15404a53dfd87fcd0},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41020834. Agents can read the archived copy with the MCP tool read_document.